NCT01001377 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 504
- group Id
- BG001
- value
- 506
- group Id
- BG002
- value
- 1010
- units
- Participants
- groups
- description
- Cetuximab 400 mg/m\^2 as an initial dose, followed by 250 mg/m\^2 intravenously (IV) every 7 days.
- id
- BG000
- title
- Cetuximab
- description
- Panitumumab 6 mg/kg IV every 14 days.
- id
- BG001
- title
- Panitumumab
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 11.2
- value
- 60.2
- group Id
- BG001
- spread
- 10.9
- value
- 59.6
- group Id
- BG002
- spread
- 11.1
- value
- 59.9
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 183
- group Id
- BG001
- value
- 187
- group Id
- BG002
- value
- 370
- title
- Female
- measurements
- group Id
- BG000
- value
- 321
- group Id
- BG001
- value
- 319
- group Id
- BG002
- value
- 640
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 230
- group Id
- BG001
- value
- 225
- group Id
- BG002
- value
- 455
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 6
- title
- Black or African American
- categories
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 13
- title
- Hispanic or Latino
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- title
- Japanese
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 5
- title
- Other
- categories
- measurements
- group Id
- BG000
- value
- 260
- group Id
- BG001
- value
- 270
- group Id
- BG002
- value
- 530
- title
- White or Caucasian
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 158
- group Id
- BG001
- value
- 158
- group Id
- BG002
- value
- 316
- title
- North America, Western Europe and Australia
- categories
- measurements
- group Id
- BG000
- value
- 346
- group Id
- BG001
- value
- 348
- group Id
- BG002
- value
- 694
- title
- Rest of World
- description
- Stratification factor. Rest of world includes South America, Asia and South Africa
- param Type
- NUMBER
- title
- Geographic region
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 165
- group Id
- BG001
- value
- 155
- group Id
- BG002
- value
- 320
- title
- Grade 0
- categories
- measurements
- group Id
- BG000
- value
- 299
- group Id
- BG001
- value
- 309
- group Id
- BG002
- value
- 608
- title
- Grade 1
- categories
- measurements
- group Id
- BG000
- value
- 40
- group Id
- BG001
- value
- 42
- group Id
- BG002
- value
- 82
- title
- Grade 2
- description
- 0 = Fully active, able to carry on all pre-disease performance without restriction. 1. = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, ie, light housework or office work. 2. = Ambulatory and capable of all self-care but unable to carry out any work. activities. Up and about \> 50% of waking hours. 3. = Capable of only limited self-care, confined to a bed or chair \> 50% of waking hours. 4. = Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair. 5. = Dead.
- param Type
- NUMBER
- title
- Eastern Cooperative Oncology Group (ECOG) performance status
- unit Of Measure
- participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 504
- group Id
- BG001
- value
- 506
- group Id
- BG002
- value
- 1010
- units
- Participants
- groups
- description
- Cetuximab 400 mg/m\^2 as an initial dose, followed by 250 mg/m\^2 intravenously (IV) every 7 days.
- id
- BG000
- title
- Cetuximab
- description
- Panitumumab 6 mg/kg IV every 14 days.
- id
- BG001
- title
- Panitumumab
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 11.2
- value
- 60.2
- group Id
- BG001
- spread
- 10.9
- value
- 59.6
- group Id
- BG002
- spread
- 11.1
- value
- 59.9
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 183
- group Id
- BG001
- value
- 187
- group Id
- BG002
- value
- 370
- title
- Female
- measurements
- group Id
- BG000
- value
- 321
- group Id
- BG001
- value
- 319
- group Id
- BG002
- value
- 640
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 230
- group Id
- BG001
- value
- 225
- group Id
- BG002
- value
- 455
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 6
- title
- Black or African American
- categories
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 13
- title
- Hispanic or Latino
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- title
- Japanese
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 5
- title
- Other
- categories
- measurements
- group Id
- BG000
- value
- 260
- group Id
- BG001
- value
- 270
- group Id
- BG002
- value
- 530
- title
- White or Caucasian
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 158
- group Id
- BG001
- value
- 158
- group Id
- BG002
- value
- 316
- title
- North America, Western Europe and Australia
- categories
- measurements
- group Id
- BG000
- value
- 346
- group Id
- BG001
- value
- 348
- group Id
- BG002
- value
- 694
- title
- Rest of World
- description
- Stratification factor. Rest of world includes South America, Asia and South Africa
- param Type
- NUMBER
- title
- Geographic region
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 165
- group Id
- BG001
- value
- 155
- group Id
- BG002
- value
- 320
- title
- Grade 0
- categories
- measurements
- group Id
- BG000
- value
- 299
- group Id
- BG001
- value
- 309
- group Id
- BG002
- value
- 608
- title
- Grade 1
- categories
- measurements
- group Id
- BG000
- value
- 40
- group Id
- BG001
- value
- 42
- group Id
- BG002
- value
- 82
- title
- Grade 2
- description
- 0 = Fully active, able to carry on all pre-disease performance without restriction. 1. = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, ie, light housework or office work. 2. = Ambulatory and capable of all self-care but unable to carry out any work. activities. Up and about \> 50% of waking hours. 3. = Capable of only limited self-care, confined to a bed or chair \> 50% of waking hours. 4. = Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair. 5. = Dead.
- param Type
- NUMBER
- title
- Eastern Cooperative Oncology Group (ECOG) performance status
- unit Of Measure
- participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle